Partial pancreatic agenesis

Partial pancreatic agenesis (also known as dorsal pancreatic agenesis or partial aplasia of the pancreas) is an extremely rare congenital malformation in which a portion of the pancreas fails to develop during embryonic life. In most cases, it is the dorsal portion of the pancreas (which forms the body and tail) that is absent, while the ventral portion (which forms the head and uncinate process) is preserved. The pancreas plays a critical role in both digestion (exocrine function, producing enzymes) and blood sugar regulation (endocrine function, producing insulin and glucagon). Because the body and tail of the pancreas contain the majority of insulin-producing beta cells, individuals with partial pancreatic agenesis may develop diabetes mellitus, which can present in childhood or adulthood. Some patients also experience exocrine pancreatic insufficiency, leading to malabsorption, steatorrhea (fatty stools), and failure to thrive in children. The condition may be discovered incidentally on abdominal imaging performed for other reasons, or it may present with symptoms of diabetes or digestive problems. In some cases, partial pancreatic agenesis occurs as an isolated finding, while in others it may be associated with additional congenital anomalies including polysplenia, congenital heart defects, or other gastrointestinal malformations. Heterozygous mutations in genes involved in pancreatic development, including the IPF1/PDX1 gene (pancreas/duodenum homeobox protein 1) and GATA6, have been identified in some familial and sporadic cases, suggesting a genetic basis in at least a subset of patients. Treatment is directed at managing the clinical consequences of the condition. Diabetes mellitus is managed with insulin therapy or oral hypoglycemic agents depending on severity. Exocrine pancreatic insufficiency is treated with pancreatic enzyme replacement therapy (PERT) to improve digestion and nutrient absorption. Regular monitoring of blood glucose levels and nutritional status is essential. Prognosis depends on the degree of pancreatic tissue absence and the severity of endocrine and exocrine dysfunction, but with appropriate management, many patients can lead relatively normal lives.

Common questions about Partial pancreatic agenesis